Showing 591-600 of 1110 results for "".
- Surgeons from Vance Thompson Vision Make Impact with Mission Trip to Hondurashttps://modernod.com/news/surgeons-from-vance-thompson-vision-make-impact-with-mission-trip-to-honduras/2479985/This spring, Russell Swan, MD, led a team of surgeons from Vance Thompson Vision and the University of Iowa, plus staff members, on a mission trip to Honduras. Russell Swan, MD, John Berdahl, MD, Brandon Baartman, MD, and Dan Bettis, MD, were joined by five team members for a week-long sur
- Oyster Point Pharma Expands Executive Leadership Team to Support Commercialization of Tyrvaya Nasal Sprayhttps://modernod.com/news/oyster-point-pharma-announces-expansion-of-executive-leadership-team-to-support-commercialization-of-tyrvaya-nasal-spray/2480475/Oyster Point Pharma announced the promotion of Barry Rosenfeld, JD, as General Counsel; and Raegan A. McClain, JD, LLM, CCEP, as Chief Compliance Officer, both of whom will join the executive leadership team. “We are thrilled to expand our executive
- Forecasting the New Normal: Experts Across Eye Care Discuss COVID-19’s Impacthttps://modernod.com/news/covid-19-forecasting-the-new-normal/2477626/In a recent episode of Ophthalmology Off the Grid, cohosts Gary Wörtz, MD, and Blake Williamson, MD, MPH, were joined by Iqbal Ike K. Ahmed, MD, FRCSC; John Kitchens, MD; and Justin Schweitzer, OD, to discuss COVID-19’s impact across eye care and share their predictions for how the current
- Opus Genetics Expands its Leadership Teamhttps://modernod.com/news/opus-genetics-expands-its-leadership-team/2480981/Opus Genetics, a gene therapy company developing treatments for inherited retinal diseases, announced the appointments of Vikram Arora, PhD, DABT, as Vice President of Non-Clinical Development; Erin O’Neil, MD, as Vice President of Clinical Development; and Sarah Tuller, JD, RAC, as Vice Pr
- Retina Specialists in US Hot Zones Report on How Offices, ORs Have Changed During COVID-19 Spreadhttps://modernod.com/news/retina-specialists-in-us-hot-zones-report-on-how-offices-ors-have-changed-during-covid-19-spread/2477521/New Retina Radio, Retina Today’s podcast, featured a conversation with three doctors from hotspots in the United States. John W. Kitchens, MD, moderated a conversation with George Williams, MD, from the Oakland University School of Medicine, outside of Detroit; Gwen Cousins, MD, from Ret
- Johnson & Johnson Vision Appoints Rajesh K. Rajpal, MD, Chief Medical Officerhttps://modernod.com/news/johnson-johnson-vision-appoints-rajesh-k-rajpal-md-chief-medical-officer/2477634/Johnson & Johnson Vision has appointed Rajesh K. Rajpal, MD, as Chief Medical Officer and Global Head of Clinical and Medical Affairs. In this role, Dr. Rajpal will lead the integration of rapidly evolving medical and clinical insights into new product development to address unmet needs of pa
- Nordic Group Appoints Eric Donnenfeld, MD, as Medical Advisory Board Chairhttps://modernod.com/news/nordic-group-appoints-eric-donnenfeld-md-as-medical-advisory-board-chair/2482132/Amring Pharmaceuticals, a subsidiary of Nordic Group, announced that ophthalmologist Eric D. Donnenfeld, MD, will chair its US Medical Advisory Board, which includes Richard Lindstrom, MD (Minnesota), Vance Thompson, MD (South Dakota), Preeya Gupta, MD (North Carolina), Paul Karpecki, O
- Equinox Ophthalmic Appoints Stuart Raetzman as Executive Chairhttps://modernod.com/news/equinox-ophthalmic-appoints-stuart-raetzman-as-executive-chair/2478384/Equinox Ophthalmic announced the appointment of Stuart Raetzman as Executive Chairman. Company founder, John Berdahl, MD, will continue to serve on the Board of Directors and as Chief Medical Officer. Equinox Ophthalmic is a company focused on addressing the unmet need in glau
- Aldeyra Therapeutics to Present Phase 2b Dry Eye Disease Results at ARVOhttps://modernod.com/news/aldeyra-therapeutics-to-present-phase-2b-dry-eye-disease-results-at-arvo/2476456/Aldeyra Therapeutics announced that John Sheppard, MD, Professor of Ophthalmology at Eastern Virginia Medical School, will present results of the phase 2b clinical trial of topical reproxalap in dry eye disea
- Retina Business Leaders Discuss How to Manage Financial Consequences of COVID-19https://modernod.com/news/retina-business-leaders-discuss-how-to-manage-covid-19s-financial-consequences/2477573/On a recent episode of New Retina Radio, John Kit